At this time, the spread of HIV and has been very very worrying. Not only affects people who have unhealthy and deviant behavior, this deadly disease even attacking the housewives and children.
Of more concern, the handling of the cases of HIV is often done too late. And the therapeutic treatment is also anti-retroviral drugs for HIV patients are given only when their immune system is already weakened due to infection.
As a result, patients with this disease more difficult to cure.
In fact, the researchers believe that the treatment in patients with HIV early conducted to reduce the spread of HIV.
Giving drugs to HIV-positive patients diagnosed soon after will be the future treatment of HIV disease.
In an experiment, as contained in the New England Journal of Medicine, researchers showed that therapy conducted one year after the patient's diagnosis, will help keep the immune system and make the virus can be monitored.
The HIV virus is no longer a 'death sentence', when the patient can get treatment and proper care and treatment.
In the care given when CD4 cells, which are part of the immune system, falls below 350 cells per cubic millimeter in the blood.
To test this theory, a study by The Spartac involving 366 patients from eight countries around the world. Some patients are given the drug tested during 12 weeks after they are diagnosed.
Others will be given the drug 48 weeks after being diagnosed.
And the third group did not take the drug until their CD4 cells reach level 350.
According to the statement of Professor Jonathan Weber, of Imperial College London, they were getting treatment after 48 weeks diagnosed with CD4 cell levels and lower exposure to the virus.
"The benefits were also still persist after you stop treatment," said Prof. Weber. Maintain the immune system is very important to prevent infection "opportunistic", such as tuberculosis. But Prof. Weber also recognize that the costs for treatment as it is going to be a problem, especially in poor countries.
Other experts from Imperial, Dr Sarah Fidler, emphasizing the benefits of maintaining a low level of virus.
"It will be very important in helping to reduce the risk of transmitting the virus to sexual partners," said Dr. Fidler.
While Dr Jimmy Whitworth, from the Wellcome Trust, who discovered the study, said:
"This study adds to the evidence that early initiation of HIV treatment will provide benefits for individuals to prevent the spread of disease and in reducing the infection to their partners." The question arises whether a series of treatments at an earlier level would be more beneficial or early treatment can be continued for the rest life. "
